Delivery Order 36C24421D0076-36C24423N0737
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 4 (VISN 4), a civilian agency within the Department of Veterans Affairs (VA), to Cytopath Biopsy Lab Inc. (operating as Cblpath), a for-profit organization. The $28,000.00 contract is for cytopathology and ThyroSeq genetic testing services to support cancer screening and diagnosis programs for veterans and active military personnel. The contract has an ultimate completion date of May 31, 2025...
- This is a firm fixed price purchase order contract awarded by the Veterans Integrated Service Network 6 (VISN 6), a civilian agency within the Department of Veterans Affairs (VA), to Cytopath Biopsy Lab Inc., doing business as Cblpath. The contract is for the provision of ThyroSeq genomic classifier tests, which are specialized molecular diagnostic tests used to evaluate thyroid cancer risk. The contract has a ceiling value of $104,000.00 and a period of performance through October 31, 2024....
- This is a $710,168.17 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA), Veterans Integrated Service Network 21, to Cytopath Biopsy Lab Inc. (operating as Cblpath) for the ThyroSeq V3 Classifier CPT molecular diagnostic testing service. The contract has an ultimate completion date of August 4, 2029 and exercises the first option year. This award is not associated with a set-aside program. Cytopath Biopsy Lab Inc. is a for-profit organization...
- This federal contract award, valued at $16,415.00, is a Delivery Order placed under an Indefinite Delivery/Indefinite Quantity (IDIQ) contract by the Veterans Integrated Service Network 2 (VISN 2), a division of the U.S. Department of Veterans Affairs (VA). The contract is for Cytopathology and ThyroSequence Testing Services to be provided by the prime contractor, Cytopath Biopsy Lab Inc., doing business as Cblpath. Cblpath is a for-profit organization that specializes in cancer screening and...
- This is a federal contract award by the U.S. Department of Veterans Affairs (VA) to Cytopath Biopsy Lab Inc., operating under the trade name Cblpath. The $148,000 firm-fixed-price delivery order contract is for ThyroSeq genetic testing services to support cancer screening and diagnosis programs for veterans and active military personnel. The contract is not set aside for any specific business category. Cytopath Biopsy Lab Inc. is a for-profit organization specializing in anatomic pathology and...
- This is a firm fixed price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide ThyroSeq laboratory tests to determine thyroid nodule malignancy for surgical decision making. The $72,000.00 award is part of an Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle between the VA and Cytopath Biopsy Lab Inc. to support cancer screening and diagnosis programs within the VA healthcare network. The contract...
- This is a firm fixed price contract awarded by the Department of Veterans Affairs (VA) to Cytopath Biopsy Lab Inc., doing business as Cblpath, for $428,000.00 to provide THYROSEC TESTING services. The contract supports the VA's cancer screening and diagnosis programs, with Cytopath Biopsy Lab providing specialized thyroid cancer diagnostic testing using its ThyroSeq molecular diagnostic platform. This includes genetic mutation analysis to evaluate malignancy of thyroid nodules detected in...
- This is a federal contract award to Cytopath Biopsy Lab Inc., operating under the trade name Cblpath, for $78,750.00 to provide ThyroSeq genomic testing services. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price pricing type, awarded by the U.S. Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 6. The contract is for the ultimate completion date of September 30, 2026. Cytopath Biopsy Lab Inc. is a for-profit organization...
- This is a firm fixed-price definitive contract awarded by the Veterans Integrated Service Network 2 (VISN 2) of the U.S. Department of Veterans Affairs (VA) to Cytopath Biopsy Lab Inc., doing business as Cblpath, for THRYOSEQUENCE TESTING services. The contract has a ceiling value of $248,145.69 and a period of performance through August 14, 2021. Cblpath is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, primarily focused on cancer screening and...
- This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide ThyroSeq genetic testing services for the VA's Veterans Integrated Service Network (VISN) 22. The $366,000 contract will support thyroid cancer screening and diagnosis programs at VA healthcare facilities in California, New Mexico, Arizona, and other regional locations. The original solicitation was a...
- 36C24421D0076Indefinite Delivery Contract
- 36C24421D0076-36C24423N0737Delivery Order
This is a firm fixed price delivery order contract awarded by the Veterans Integrated Service Network 4 (VISN 4), which is part of the U.S. Department of Veterans Affairs (VA), to Cytopath Biopsy Lab Inc., doing business as Cblpath. The contract is for the provision of cytopathology and ThyroSeq genomic testing services, with a ceiling value of $8,000. Cytopath Biopsy Lab Inc. is a for-profit organization that specializes in cancer screening and diagnostic laboratory services, particularly for thyroid cancer utilizing its proprietary ThyroSeq technology. This contract supports the VA's cancer screening and diagnostic programs for veterans, building on Cytopath Biopsy Lab Inc.'s past experience providing similar ThyroSeq testing services to the VA and the Defense Health Agency. The contract does not have a set-aside designation and is expected to be completed by May 31, 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | ($90k) | 7/30/24 | |
| Not listed | Not listed | $98.3k | 5/25/23 |